1-9 of 9
Roman Gulati
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sensitivity Measures in Studies of Cancer Early Detection Biomarkers

Yibai Zhao, Roman Gulati, Jane Lange, Antonio Olivas-Martinez, Sana Raoof, Yingye Zheng, Ziding Feng, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev OF1–OF8.
https://doi.org/10.1158/1055-9965.EPI-24-1849
Published: 30 April 2025
View articletitled, Sensitivity Measures in Studies of Cancer Early Detection Biomarkers
Open the PDF for Sensitivity Measures in Studies of Cancer Early Detection Biomarkers in another window
Includes: Supplementary data
Journal Articles

Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling

Jane M. Lange, Kemal Caglar Gogebakan, Roman Gulati, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2024) 33 (6): 830–837.
https://doi.org/10.1158/1055-9965.EPI-23-1470
Published: 03 June 2024
View articletitled, Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling
Open the PDF for Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling in another window
Includes: Supplementary data
Journal Articles

Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?

Lukas Owens, Kemal Caglar Gogebakan, Usha Menon, Roman Gulati, Noel S. Weiss, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2023) 32 (6): 741–743.
https://doi.org/10.1158/1055-9965.EPI-22-1307
Published: 01 June 2023
View articletitled, Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?
Open the PDF for Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? in another window
Journal Articles

Stage Shift as an Endpoint in Cancer Screening Trials: Implications for Evaluating Multicancer Early Detection Tests

Lukas Owens, Roman Gulati, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2022) 31 (7): 1298–1304.
https://doi.org/10.1158/1055-9965.EPI-22-0024
Published: 01 July 2022
View articletitled, Stage Shift as an Endpoint in Cancer Screening Trials: Implications for Evaluating Multicancer Early Detection Tests
Open the PDF for Stage Shift as an Endpoint in Cancer Screening Trials: Implications for Evaluating Multicancer Early Detection Tests in another window
Journal Articles

A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing

Boshen Jiao, Roman Gulati, Hormuzd A. Katki, Philip E. Castle, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2022) 31 (1): 38–44.
https://doi.org/10.1158/1055-9965.EPI-21-0380
Published: 01 January 2022
View articletitled, A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing
Open the PDF for A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection Testing in another window
Includes: Supplementary data
Journal Articles

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms

Roman Gulati, Heather H. Cheng, Paul H. Lange, Peter S. Nelson, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2017) 26 (2): 222–227.
https://doi.org/10.1158/1055-9965.EPI-16-0434
Published: 05 February 2017
View articletitled, Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms
Open the PDF for Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms in another window
Journal Articles

Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer

Jeanette K. Birnbaum, Ziding Feng, Roman Gulati, Jing Fan, Yair Lotan, John T. Wei, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2015) 24 (4): 677–682.
https://doi.org/10.1158/1055-9965.EPI-14-1224
Published: 31 March 2015
View articletitled, Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer
Open the PDF for Projecting Benefits and Harms of Novel Cancer Screening Biomarkers: A Study of PCA3 and Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models

Roman Gulati, Elisabeth M. Wever, Alex Tsodikov, David F. Penson, Lurdes Y.T. Inoue, Jeffrey Katcher, Shih-Yuan Lee, Eveline A.M. Heijnsdijk, Gerrit Draisma, Harry J. de Koning, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2011) 20 (5): 740–750.
https://doi.org/10.1158/1055-9965.EPI-10-0718
Published: 04 May 2011
View articletitled, What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models
Open the PDF for What If I Don't Treat My PSA-Detected Prostate Cancer? Answers from Three Natural History Models in another window
Includes: Supplementary data
Journal Articles

Effect of Population Trends in Body Mass Index on Prostate Cancer Incidence and Mortality in the United States

Megan Dann Fesinmeyer, Roman Gulati, Steve Zeliadt, Noel Weiss, Alan R. Kristal, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2009) 18 (3): 808–815.
https://doi.org/10.1158/1055-9965.EPI-08-0784
Published: 09 March 2009
View articletitled, Effect of Population Trends in Body Mass Index on Prostate Cancer Incidence and Mortality in the United States
Open the PDF for Effect of Population Trends in Body Mass Index on Prostate Cancer Incidence and Mortality in the United States in another window